Joined March 2016
- Tweets 303
- Following 87
- Followers 102
- Likes 515
8 Photos and videos
Sridhar Nimmagadda retweeted
28 Sep 2021
The new labeling agent could help us monitor differences in checkpoint expression across the body and allow oncologists to compare the performance of different antibody therapies. bit.ly/3kNTqND x.com/HopkinsMedNews/status/… 2/3
2
4
9
Sridhar Nimmagadda retweeted
28 Sep 2021
We show that PD-L1 imaging agents can be used as a common denominator to compare the activity of different antibodies. This will allow us to compare the efficacy of different antibodies early in therapy, identify better drugs and optimize the doses. bit.ly/3kNTqND 3/3
1
3
6
Sridhar Nimmagadda retweeted
28 Sep 2021
Collecting biopsies isn't easy for patients who have multiple #Cancers. So, @HopkinsMedicine researchers developed an agent that marks so-called immune checkpoints in the whole body non-invasively for imaging. 1/3
bit.ly/3kNTqND
1
6
8
Congratulations to Jason Lewis, Ph.D. and Martin Pomper, Ph.D.!
Dr. Lewis and Dr. Pomper will receive our highest honor, the Gold Medal Award for Outstanding Contributions to Molecular Imaging at #WMIC2021.
We hope to see you there!
Register here: ow.ly/hBGq50GhrpR
2
6
55
Sridhar Nimmagadda retweeted
10 Sep 2021
Nice work by Dr. Sridhar Nimmagadda & colleagues @Imaging4Health We now have an exciting study of a novel PD-L1 PET tracer (developed by Dr. Nimmagadda in his lab at Johns Hopkins) open for pts starting pembrolizumab for lung cancer @HopkinsThoracic @hopkinskimmel #LCSM
10 Sep 2021
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics | PNAS pnas.org/content/118/37/e210…
3
9
Sridhar Nimmagadda retweeted
14 Oct 2019
Dr. Martin Pomper Past-President of WMIS delivered a compelling Plenary at ESNM today where he showed his Journey imaging PSMA starting in 1997. He stated PSMA imaging is leading us in the direction of a paradigm shift and a path to cure with imaging.
6
13
15 Oct 2019
Congratulations Jason! A fantastic recognition to everything that you do.
Congratulations to this week's, and our first, @AcadRad #ImagingInnovator! We are so pleased to announce @LewisLabMSKCC has recently been awarded an @NCIMedia Outstanding Investigator (R35) Award. TY to Dr. Lewis for all of your hard work and your contributions to this community!
5
Sridhar Nimmagadda retweeted
12 Oct 2019
The first woman to be awarded a #NobelPrize, the first individual to be awarded two Nobel Prizes and still today the only individual with two Nobel Prizes in two different scientific categories - Marie Skłodowska Curie.
42
1,963
6,411
11 Oct 2019
Registration for our workshop @Hopkins_Rad
@HopkinsMedicine "Precision Imaging Agents and Theranostics: Concept to Clinic” is now open!
Emphasis on clinical translation of #PET and #MR imaging agents. Approved for #CME credits.
hopkinscme.cloud-cme.com/def…
RTs are appreciated.
1
6
11
Sridhar Nimmagadda retweeted
7 Oct 2019
2019 Medicine Laureates William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza have identified molecular machinery that regulates the activity of genes in response to varying levels of oxygen.
#NobelPrize
8
1,077
2,201
Sridhar Nimmagadda retweeted
Congratulations to Dr Gregg Semenza from @HopkinsMedicine on being awarded the 2019 @NobelPrize in Physiology or Medicine for work focused on how cells detect and respond to oxygen. He shares the honor with Dr William Kaelin and Sir Peter Ratcliffe.
hub.jhu.edu/2019/10/07/gregg…
11
67
Sridhar Nimmagadda retweeted
3 Oct 2019
Come and join our team! #PhD opportunity on @FindAPhD: We are looking for a talented student interested in understanding how #cancer cells respond to #DNAdamage. We can even visualise this process in vivo! Details here:
findaphd.com/search/ProjectD…. Pls get in touch. RTs appreciated
2
18
13
2 Oct 2019
Transformative work Mikhail and team. Congratulations!!!
27 Sep 2019
Ultrasound imaging of gene expression in mammalian cells. Congratulations @farhadi_arash, Gabrielle Ho, @dannypsawyer, Ray Bourdeau and everyone who helped with this project. Thanks @sciencemagazine for publishing this work and for this highlight: sciencemag.org/news/2019/09/…
1
3
With a 5-year min follow-up, the combination of nivolumab plus ipilimumab associated with 5-year survival of 52% in patients with metastatic #melanoma, compared with 44% for nivolumab alone and 26% for ipilimumab alone. See the CheckMate 067 trial. #ESMO19 nej.md/2mKBiso
5
216
434
25 Sep 2019
We are thrilled to have @SimonRCherry at @Hopkins_Rad and exited to learn more about @TotalBodyPET project!
1
7
Sridhar Nimmagadda retweeted
Our lab’s inaugural manuscript is out (PMID: 31424293)!!! First #tweetorial (1/n) #chemtwitter #radonc #academicchatter #newPI #sciencetwitter #livercancer
tinyurl.com/y3rh7hq4
5
12
39
Sridhar Nimmagadda retweeted
Dr. Ana Kiess @HopkinsMedicine and I wrote an @ASTRO_org blog post for #radonc docs on radiopharmaceutical therapies in #oncology. Don't forget to register for the #Theranostics Training Course at #ASTRO19 on Sept 14 2019! astro.org/Blog/July-2019/Rad…
1
6
Sridhar Nimmagadda retweeted
24 Jul 2019
Best in the business...
For each eligible employee, @JohnsHopkins pays for 50% of each dependent child's undergraduate tuition fees.
This is a $53,740 per child, per year. If both partners/spouses are FTEs, then the benefit is $107,480.
Your kid(s) can enroll in any university
9
18
122
28 Jun 2019
Great pic Assaf, congratulations!!
28 Jun 2019
What a great photo of the “Gilad lab” at @MSUIQ. We grew from 1 to 15 in two years. Couldn’t ask for a better group of scientists to work with.
4